Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
- PMID: 40774808
- DOI: 10.1183/13993003.01040-2025
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
Similar articles
-
Pericardial Effusion and Prostacyclin Analog Toxicity After Initiation of Sotatercept.Pulm Circ. 2025 Jul 27;15(3):e70141. doi: 10.1002/pul2.70141. eCollection 2025 Jul. Pulm Circ. 2025. PMID: 40717711 Free PMC article.
-
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.Adv Ther. 2025 Aug;42(8):3902-3921. doi: 10.1007/s12325-025-03241-4. Epub 2025 Jun 17. Adv Ther. 2025. PMID: 40526255 Free PMC article.
-
Efficacy and safety of sotatercept in pulmonary arterial hypertension: a meta-analysis of randomized controlled trials.Expert Rev Respir Med. 2025 Jul 6:1-9. doi: 10.1080/17476348.2025.2530201. Online ahead of print. Expert Rev Respir Med. 2025. PMID: 40611681 Review.
-
Efficacy and safety of sotatercept in pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 16. doi: 10.1007/s00210-025-04424-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40668414 Review.
-
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA.Eur Respir J. 2025 Jul 24;66(1):2401435. doi: 10.1183/13993003.01435-2024. Print 2025 Jul. Eur Respir J. 2025. PMID: 39978862 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources